Interact to see
Advertisement
Advertisement
HBGHX vs JNGLX
HBGHX vs JNGLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
HBGHX vs. JNGLX commentary
Aug 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBGHX is a Buy and JNGLX is a Buy.
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.29B vs. HBGHX (102M). JNGLX pays higher dividends than HBGHX: JNGLX (0.36) vs HBGHX (0.00). HBGHX was incepted earlier than JNGLX: HBGHX (25 years) vs JNGLX (27 years). HBGHX (1.18) is less costly to investors than JNGLX (0.80). HBGHX is a more actively managed with annual turnover of: 42.00 vs. JNGLX (35.00). HBGHX has a lower initial minimum investment than JNGLX: HBGHX (0) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -14.24 vs. HBGHX (-16.13). JNGLX return over 5 years is better than : 5.06 vs. HBGHX (-43.47).
| HBGHX | JNGLX | HBGHX / JNGLX | |
| Total Expense Ratio | 1.18 | 0.80 | 147% |
| Annual Report Gross Expense Ratio | 1.18 | 0.80 | 147% |
| Fund Existence | 25 years | 27 years | - |
| Gain YTD | -4.739 | 0.884 | -536% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 102M | 4.29B | 2% |
| Annual Yield % from dividends | 0.00 | 0.36 | - |
| Returns for 1 year | -16.13 | -14.24 | 113% |
| Returns for 3 years | -28.38 | 6.21 | -457% |
| Returns for 5 years | -43.47 | 5.06 | -860% |
| Returns for 10 years | -58.66 | 12.18 | -482% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FCUIX | 20.41 | 0.03 | +0.15% |
| NYLI PineStone U.S. Equity Class I | |||
| OEGCX | 19.75 | -0.05 | -0.25% |
| Invesco Discovery Mid Cap Growth C | |||
| MUSBX | 36.64 | -0.13 | -0.35% |
| MFS Blended Research Core Equity B | |||
| FRSLX | 26.87 | -0.10 | -0.37% |
| Nuveen Small/Mid Cap Growth Opp A | |||
| CUSIX | 14.11 | -0.08 | -0.56% |
| Cullen Small Cap Value I | |||